로딩 중…
지수 로딩 중…
유투바이오
221800· KOSDAQ· Health Care· Health Care Equipment & Services
₩7,240-5.73%
2026-06-19
Price Chart
유투바이오+125.90%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 118.15B KRW |
| Revenue | 26.95B KRW |
| Net Income | -828.7M KRW |
| Total Assets | 66.58B KRW |
| Net Assets | 53.81B KRW |
| Employees | 101 |
| Value | |
| P/B | 2.20x |
| P/S | 4.38x |
| FCF Yield | -1.40% |
| Profitability | |
| ROE | -1.54% |
| ROA | -1.24% |
| Op. Margin | -6.46% |
| Revenue Growth | 24.16% |
| Financial Health | |
| Debt Ratio | 123.73% |
| Total Debt | 0 KRW |
| FCF | -1.65B KRW |
| Cash | 16.79B KRW |
| Current Ratio | 4.02x |
| Dividend | |
| Div. Yield | 1.30% |
| Div. Growth | -83.24% |
| Performance | |
| 1Y Return | 125.90% |
| 1M Return | -42.26% |
| From 52W High | -77.93% |
| 1Y MDD | -74.33% |
| Trading | |
| Volume | 58,788 shares |
| Foreign Own. | 0.48% |
| Per Share | |
| EPS | -133 KRW |
| BPS | 3,332 KRW |
Company Info
Established in 2009, this company was listed on the KONEX market in 2015 and transferred to the KOSDAQ market in 2023. It operates in vitro diagnostic testing services and medical IT solutions, collecting specimens from hospitals and clinics nationwide through directly managed stores and agencies, and delivering analysis results via partner medical institutions. The company is pursuing pharmaceutical clinical services with partner medical institutions and U2Biome, an NGS-based personalized health management solution, as new growth engines. U2Bio was established in 2009 and is headquartered in Songpa-gu, Seoul Metropolitan City.